Development of the First Potential Nonpeptidic Positron Emission Tomography Tracer for the Imaging of CCR2 Receptors

被引:6
作者
Wagner, Stefan [1 ]
Gatti, Fernando de Moura [2 ,10 ]
Silva, Daniel G. [3 ]
Zacarias, Natalia V. Ortiz [4 ]
Zweemer, Annelien J. M. [4 ]
Hermann, Sven [3 ]
De Maria, Monica [5 ]
Koch, Michael [6 ]
Weiss, Christina [6 ]
Schepmann, Dirk [2 ]
Heitman, Laura H. [4 ]
Tschammer, Nuska [7 ]
Kopka, Klaus [8 ,9 ]
Junker, Anna [2 ,3 ]
机构
[1] Univ Hosp Munster, Dept Nucl Med, Albert Schweitzer Campus 1,Bldg A1, D-48149 Munster, Germany
[2] Univ Munster, Inst Pharmazeut & Med Chem, Corrensstr 48, D-48149 Munster, Germany
[3] European Inst Mol Imaging EIMI, Waldeyerstr 15, D-48149 Munster, Germany
[4] Leiden Univ, Leiden Acad Ctr Drug Res LACDR, Einsteinweg 55, NL-2333 CC Leiden, Netherlands
[5] Friedrich Alexander Univ, Dept Dev Biol, Staudtstr 5, D-91058 Erlangen, Germany
[6] Bayer AG, Res & Dev Lead Discovery Wuppertal, Aprather Weg 18a,Gebaude 456, D-42096 Wuppertal, Germany
[7] Friedrich Alexander Univ Erlangen Nurnberg, Emil Fischer Ctr, Dept Chem & Pharm, Schuhstr 19, D-91052 Erlangen, Germany
[8] Helmholtz Zentrum Dresden Rossendorf, Inst Radiopharmazeut Krebsforsch, Bautzner Landstr 400, D-01328 Dresden, Germany
[9] Tech Univ Dresden, Fac Chem & Food Chem, D-01062 Dresden, Germany
[10] Univ Sao Paulo, Fac Ciencias Farmaceut, Av Prof Lineu Prestes 580, BR-05508900 Sao Paulo, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
CCR2; CCR5; antagonists; chemokine receptors; molecular imaging; PET; radiolabeling; TAK-779; FUNCTIONAL EXPRESSION; BIOLOGICAL EVALUATION; CHEMOKINE; CLONING;
D O I
10.1002/cmdc.202000728
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Herein we report the design and synthesis of a series of highly selective CCR2 antagonists as F-18-labeled PET tracers. The derivatives were evaluated extensively for their off-target profile at 48 different targets. The most potent and selective candidate was applied in vivo in a biodistribution study, demonstrating a promising profile for further preclinical development. This compound represents the first potential nonpeptidic PET tracer for the imaging of CCR2 receptors.
引用
收藏
页码:640 / 645
页数:6
相关论文
共 17 条
  • [1] [Anonymous], 2008, ANGEW CHEM-GER EDIT, DOI [10.1002/ange.200800222, DOI 10.1002/ANGE.200800222]
  • [2] Tissue Resident CCR2-and CCR2+Cardiac Macrophages Differentially Orchestrate Monocyte Recruitment and Fate Specification Following Myocardial Injury
    Bajpai, Geetika
    Bredemeyer, Andrea
    Li, Wenjun
    Zaitsev, Konstantin
    Koenig, Andrew L.
    Lokshina, Inessa
    Mohan, Jayaram
    Ivey, Brooke
    Hsiao, His-Min
    Weinheimer, Carla
    Kovacs, Attila
    Epelman, Slava
    Artyomov, Maxim
    Kreisel, Daniel
    Lavine, Kory J.
    [J]. CIRCULATION RESEARCH, 2019, 124 (02) : 263 - 278
  • [3] Cloning, in vitro expression, and functional characterization of a novel human CC chemokine of the monocyte chemotactic protein (MCP) family (MCP-4) that binds and signals through the CC chemokine receptor 2B
    Berkhout, TA
    Sarau, HM
    Moores, K
    White, JR
    Elshourbagy, N
    Appelbaum, E
    Reape, TJ
    Brawner, M
    Makwana, J
    Foley, JJ
    Schmidt, DB
    Imburgia, C
    McNulty, D
    Matthews, J
    ODonnell, K
    OShannessy, D
    Scott, M
    Groot, PHE
    Macphee, C
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (26) : 16404 - 16413
  • [4] Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases
    Bose, Shambhunath
    Cho, Jungsook
    [J]. ARCHIVES OF PHARMACAL RESEARCH, 2013, 36 (09) : 1039 - 1050
  • [5] Bruehlmeier M, 2004, J NUCL MED, V45, P1851
  • [6] Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP-1 alpha, MIP-1 beta, and RANTES
    Combadiere, C
    Ahuja, SK
    Tiffany, HL
    Murphy, PM
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1996, 60 (01) : 147 - 152
  • [7] Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders
    Fantuzzi, Laura
    Tagliamonte, Maria
    Gauzzi, Maria Cristina
    Lopalco, Lucia
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2019, 76 (24) : 4869 - 4886
  • [8] The CCR2 receptor as a therapeutic target
    Feria, M
    Díaz-González, F
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (01) : 49 - 57
  • [9] Heo GS, 2019, J NUCL MED, V60
  • [10] Synthesis, binding affinity and structure-activity relationships of novel, selective and dual targeting CCR2 and CCR5 receptor antagonists
    Junker, Anna
    Kokornaczyk, Artur K.
    Zweemer, Annelien J. M.
    Frehland, Bastian
    Schepmann, Dirk
    Yamaguchi, Junichiro
    Itami, Kenichiro
    Faust, Andreas
    Hermann, Sven
    Wagner, Stefan
    Schaefers, Michael
    Koch, Michael
    Weiss, Christina
    Heitman, Laura H.
    Kopka, Klaus
    Wuensch, Bernhard
    [J]. ORGANIC & BIOMOLECULAR CHEMISTRY, 2015, 13 (08) : 2407 - 2422